Hal Kennedy

1.5k total citations
21 papers, 1.3k citations indexed

About

Hal Kennedy is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Hal Kennedy has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Hal Kennedy's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Hal Kennedy is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Hal Kennedy collaborates with scholars based in United States, Netherlands and Italy. Hal Kennedy's co-authors include Santica M. Marcovina, John J. Albers, S Marcovina, J J Albers, J J Albers, W. Harry Hannon, L. Omar Henderson, N.H. Chapman, Ellen M. Wijsman and Marian C. Cheung and has published in prestigious journals such as Diabetes, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Hal Kennedy

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hal Kennedy United States	17	886	613	320	290	162	21	1.3k
Daniel M Hoefner United States	12	676 0.8×	512 0.8×	224 0.7×	309 1.1×	121 0.7×	21	1.1k
Moira A. Clay Australia	14	592 0.7×	554 0.9×	211 0.7×	180 0.6×	139 0.9×	19	1.1k
Margaret R. Diffenderfer United States	21	923 1.0×	700 1.1×	320 1.0×	272 0.9×	108 0.7×	50	1.4k
Daniel Rader United States	4	658 0.7×	589 1.0×	224 0.7×	274 0.9×	132 0.8×	9	1.1k
A Rubinstein Israel	16	607 0.7×	671 1.1×	216 0.7×	441 1.5×	137 0.8×	35	1.2k
Gissette Reyes‐Soffer United States	18	672 0.8×	369 0.6×	203 0.6×	406 1.4×	141 0.9×	38	1.1k
M van Linde-Sibenius Trip Netherlands	8	706 0.8×	480 0.8×	216 0.7×	401 1.4×	94 0.6×	8	1.2k
Kashif Jafri United States	10	968 1.1×	862 1.4×	300 0.9×	374 1.3×	237 1.5×	13	1.9k
W Jaroß Germany	19	648 0.7×	259 0.4×	187 0.6×	226 0.8×	131 0.8×	73	1.3k
Isabelle L. Ruel Canada	21	1.0k 1.1×	597 1.0×	370 1.2×	328 1.1×	134 0.8×	69	1.5k

Countries citing papers authored by Hal Kennedy

Since Specialization

Citations

This map shows the geographic impact of Hal Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal Kennedy more than expected).

Fields of papers citing papers by Hal Kennedy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hal Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal Kennedy. The network helps show where Hal Kennedy may publish in the future.

Co-authorship network of co-authors of Hal Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of Hal Kennedy. A scholar is included among the top collaborators of Hal Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hal Kennedy. Hal Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vuletic, Simona, Hal Kennedy, John J. Albers, et al.. (2014). Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables. Multiple Sclerosis and Related Disorders. 3(4). 533–541. 17 indexed citations

Albers, John J., Joseph R. Day, Gertrud Wolfbauer, et al.. (2011). Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1814(7). 908–911. 14 indexed citations

Lamon‐Fava, Stefania, Santica M. Marcovina, John J. Albers, et al.. (2011). Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study. Journal of Lipid Research. 52(6). 1181–1187. 73 indexed citations

Albers, John J., Hal Kennedy, & Santica M. Marcovina. (2010). Evaluation of a new homogenous method for detection of small dense LDL cholesterol: Comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation. Clinica Chimica Acta. 412(7-8). 556–561. 30 indexed citations

Cheung, Marian C., John J. Albers, Hal Kennedy, et al.. (2010). Association of Apo(a)isoform size with dyslipoproteinemia in male Venous Thrombosis patients. Clinica Chimica Acta. 411(17-18). 1279–1283. 5 indexed citations

Vuletic, Simona, Ge Li, Elaine R. Peskind, et al.. (2008). Apolipoprotein E Highly Correlates with AβPP- and Tau-Related Markers in Human Cerebrospinal Fluid. Journal of Alzheimer s Disease. 15(3). 409–417. 11 indexed citations

Vuletic, Simona, Elaine R. Peskind, Santica M. Marcovina, et al.. (2005). Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. Journal of Neuroscience Research. 80(3). 406–413. 43 indexed citations

Cheung, Marian C., Robert H. Knopp, Barbara M. Retzlaff, et al.. (2002). Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(1). 53–59. 30 indexed citations

Murdoch, Susan J., Gertrud Wolfbauer, Hal Kennedy, et al.. (2002). Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. Journal of Lipid Research. 43(2). 281–289. 32 indexed citations

10.

Murdoch, Susan J., Molly C. Carr, Hal Kennedy, John D. Brunzell, & John J. Albers. (2002). Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. Journal of Lipid Research. 43(8). 1256–1263. 26 indexed citations

11.

Cheung, Marian C., Gertrud Wolfbauer, Hal Kennedy, B. Greg Brown, & John J. Albers. (2001). Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537(2). 117–124. 18 indexed citations

12.

Paigen, Beverly, et al.. (1999). Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice. International Journal of Clinical & Laboratory Research. 29(1). 14–21. 13 indexed citations

13.

Marcovina, Santica M., Hal Kennedy, Gabriele Bittolo Bon, et al.. (1999). Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania. Arteriosclerosis Thrombosis and Vascular Biology. 19(5). 1250–1256. 43 indexed citations

14.

Albers, John J., Wendy A. Pitman, Gertrud Wolfbauer, et al.. (1999). Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains. Journal of Lipid Research. 40(2). 295–301. 40 indexed citations

15.

Marcovina, Santica M., et al.. (1996). Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. Journal of Lipid Research. 37(12). 2569–2585. 196 indexed citations

16.

Albers, J J, Hal Kennedy, & Santica M. Marcovina. (1996). Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data.. Journal of Lipid Research. 37(1). 192–196. 66 indexed citations

17.

Purnell, Jonathan Q., Santica M. Marcovina, John E. Hokanson, et al.. (1995). Levels of Lipoprotein(a), Apolipoprotein B, and Lipoprotein Cholesterol Distribution in IDDM: Results From Follow-Up in the Diabetes Control and Complications Trial. Diabetes. 44(10). 1218–1226. 55 indexed citations

18.

Marcovina, S, et al.. (1994). International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clinical Chemistry. 40(4). 586–592. 205 indexed citations

19.

Albers, J J, S Marcovina, & Hal Kennedy. (1992). International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-I and B. II. Evaluation and Selection of Candidate Reference Materials. Clinical Chemistry. 38(5). 658–662. 94 indexed citations

20.

Kennedy, Hal, Elizabeth M. Tucker, S. W. Clarke, et al.. (1988). Production and Characterization of Bovine Monoclonal Antibodies to Respiratory Syncytial Virus. Journal of General Virology. 69(12). 3023–3032. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact